Biotechnology

The iShares Biotechnology ETF (IBB) appears to be recently completed a multiyear period of price consolidation.  Notice the significantly higher low during the 2009 basing period relative to the 2003 basing period.  It's recent multiyear high is very bullish.

iShares Nasdaq Biotechnology ETF (IBB)
Top holdings
Amgen, Inc. 9.13%
Teva Pharmaceutical Industries, Ltd. ADR 6.78%
Celgene Corporation 6.17%
Gilead Sciences, Inc. 5.72%
Vertex Pharmaceuticals 3.62%
Genzyme Corporation 3.61%
Biogen Idec, Inc. 3.20%
Alexion Pharmaceuticals, Inc. 2.83%
Perrigo Company 2.79%
Illumina, Inc. 2.76%